Form D — Shuttle Pharmaceuticals Holdings, Inc.

0001641172-25-016626 · filed Jun 26, 2025

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry: Pharmaceuticals
Exemptions: 06b
Reported offering amount: $4,250,000
Reported amount sold: $4,250,000
Minimum investment: $0
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: Shuttle Pharmaceuticals Holdings, Inc.
CIK: 1757499
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: —
Address: 401 PROFESSIONAL DRIVE
GAITHERSBURG, MD 20879
Phone: (240) 403-4212

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Christopher Cooper · Executive Officer

Gaithersburg, MD Find on LinkedIn ↗
Peter Dritschilo · Executive Officer

Gaithersburg, MD Find on LinkedIn ↗
Mira Jung · Executive Officer

Gaithersburg, MD Find on LinkedIn ↗
Tyvin Rich · Executive Officer

Gaithersburg, MD Find on LinkedIn ↗
Timothy Lorber · Executive Officer

Gaithersburg, MD Find on LinkedIn ↗
George Scorcis · Director

Gaithersburg, MD Find on LinkedIn ↗
Steven Richards · Director

Gaithersburg, MD Find on LinkedIn ↗
Oleh Nabyt · Director

Gaithersburg, MD Find on LinkedIn ↗
Joseph Tung · Director

Gaithersburg, MD Find on LinkedIn ↗

Other filings from this issuer

View the original filing on SEC EDGAR ↗